Search Results - "Poos AM"

Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

Authors: Bergiers, Isabelle Köse, Murat Cem Skerget, Sheri et al.

Source: PLoS Genetics. 10/7/2025, Vol. 21 Issue 10, p1-29. 29p.

Temporal genomic dynamics shape clinical trajectory in multiple myeloma.

Authors: Maura F Kaddoura M Poos AM et al.

Source: Nature genetics [Nat Genet] 2025 Sep; Vol. 57 (9), pp. 2203-2214. Date of Electronic Publication: 2025 Aug 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma.

Authors: Ju, Fei-Er Huang, Bei-Hui Wu, Hao et al.

Source: Journal of Translational Medicine. 6/16/2025, Vol. 23 Issue 1, p1-17. 17p.

Genomic profiling enables personalized strategies to overcome drug resistance in multiple myeloma.

Authors: Zeng F Taki A

Source: Discover oncology [Discov Oncol] 2026 Mar 14; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

CORRELATION ANALYSIS OF SERUM CCL3, TRACP-5b, AND SCLEROSTIN WITH THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS.

Alternate Title: ANALIZA KORELACIJE SERUMSKE CCL3, TRACP-5b I SKLEROSTINA SA PROGNOZOM KOD PACIJENATA SA MULTIPLIM MIJELOMOM.

Authors: Jiang, Cuimei Sun, ManMan Gao, Dashan et al.

Source: Journal of Medical Biochemistry. Jun2026, Vol. 45 Issue 6, p1286-1294. 9p.

Single-cell technologies in deciphering drug resistance of multiple myeloma: mechanistic insights and clinical translation prospects.

Authors: Wu, Jun Dong, Haibo Xu, Xuejing et al.

Source: Leukemia & Lymphoma. May2026, Vol. 67 Issue 6, p1231-1246. 16p.

A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma.

Authors: Chen, Hong Han, Jingxin Huang, Haozhe et al.

Source: EJNMMI Research. 10/15/2025, Vol. 15 Issue 1, p1-13. 13p.

An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.

Authors: Morgan, Gareth J. Nau, Allison N. Wong, Sherry et al.

Source: Amyloid. Jun2025, Vol. 32 Issue 2, p129-138. 10p.

T-lymphocytes suppression by CD14⁺ monocytes with high expression of ULK2 in patients with multiple myeloma.

Authors: Peng, Fengping Liu, Zhaoyun Jiang, Fengjuan et al.

Source: Journal of Translational Medicine. 5/7/2025, Vol. 23 Issue 1, p1-14. 14p.

Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.

Authors: Heinemann L Möllers KM Ahmed HMM et al.

Source: Frontiers in oncology [Front Oncol] 2022 Jun 20; Vol. 12, pp. 874325. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

The transcription factor PITX1 cooperates with super-enhancers to regulate the expression of DUSP4 and inhibit pyroptosis in pulmonary artery smooth muscle cells.

Authors: Zhang, Jingya Song, Yuyu Wang, Xinru et al.

Source: Respiratory Research. 4/16/2025, Vol. 26 Issue 1, p1-20. 20p.

Exosome-transmitted HSPA9 facilitates bortezomib resistance by targeting TRIP13/USP1 signaling in multiple myeloma.

Authors: Shi, Min Shen, Na Liu, Xiangyu et al.

Source: Cell Communication & Signaling. 3/26/2025, Vol. 23 Issue 1, p1-17. 17p.

Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients.

Authors: Chen, Xi Luo, Tianchen Zhang, Wenhui et al.

Source: BMC Medical Genomics. 3/14/2025, Vol. 18 Issue 1, p1-14. 14p.

Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation and uncovering functional insights in colorectal cancer.

Authors: Chen, Jingfeng Hu, Qin Zhang, Cong et al.

Source: BMC Cancer. 2/13/2025, Vol. 25 Issue 1, p1-22. 22p.

Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.

Authors: Yang J Zhang M Zhong Y et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 29; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Artificial intelligence reshaping the paradigm of hematologic malignancy diagnosis and treatment: From static assessment to dynamic precision management.

Authors: Li Z Zhao J Huang L et al.

Source: Annals of hematology [Ann Hematol] 2026 Apr 14; Vol. 105 (5). Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Toward a cure for multiple myeloma within a decade.

Authors: Mohty M Malard F Facon T et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 10; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Single-cell profiling reveals MIF-mediated immune evasion and CD8 + T cell exhaustion in relapsed multiple myeloma.

Authors: Ma J Gao S Liu S et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 Mar 08; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Immune heterogeneity at diagnosis influences treatment response and survival in multiple myeloma.

Authors: Wang Y Lan T Gu S et al.

Source: Discover oncology [Discov Oncol] 2026 Feb 06; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 06.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Authors: Baďurová K Kapustová V Kotulová J et al.

Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 475-494. Date of Electronic Publication: 2026 Mar 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE